prabotulinumtoxinA-xvfs
ApprovedRecruiting 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Neck Muscle Issue
Conditions
Neck Muscle Issue
Trial Timeline
May 14, 2025 → Mar 1, 2026
NCT ID
NCT06903975About prabotulinumtoxinA-xvfs
prabotulinumtoxinA-xvfs is a approved stage product being developed by Evolus for Neck Muscle Issue. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06903975. Target conditions include Neck Muscle Issue.
What happened to similar drugs?
3 of 20 similar drugs in Neck Muscle Issue were approved
Approved (3) Terminated (0) Active (17)
Hype Score Breakdown
Clinical
20
Activity
15
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06903975 | Approved | Recruiting |
Competing Products
20 competing products in Neck Muscle Issue